Adverse kidney outcomes of CDK 4/6 inhibitors for metastatic breast cancer

Hanna, PE; Strohbehn, IA; Moreno, D; Harden, D; Seethapathy, R; Sawtell, R; Wang, QY; Ouyang, TQ; Katz-Agranov, N; Dinulos, J; Wander, SA; Gupta, S; Sise, ME

Sise, ME (通讯作者)，Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA 02114 USA.

NPJ BREAST CANCER, 2023; 9 (1):

Abstract

Cyclin-dependent kinase (CDK) 4/6 inhibitors have significantly improved overall and progression free survival of patients with metastatic breast canc......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索